Tejaswi Kompala retweeted
🚨 BREAKING: Zepbound (#Tirzepatide) becomes the first-ever FDA-approved drug for Obstructive Sleep Apnea (OSA)! 🌟
fda.gov/news-events/press-an…
Tejaswi Kompala retweeted
If MAHA cares about “making Americans healthy” I expect to see:
Expansion of Medicare & Medicaid
Vaccine requirements for schools
Affordable healthcare for ALL
Implementing modern agriculture tools for food crops
Addressing lies about conventionally-grown foods
1/
Tejaswi Kompala retweeted
Just asked @ZekeEmanuel about what we should be doing next for America’s health to have the greatest impact. His answer made me jump out of my chair.
Invest in our children. The earlier, the better. Their nutrition, their education, the right early inventions. We can afford it *and* it pays for itself.
More to come on the Second Opinion pod!
Tejaswi Kompala retweeted
Today is the last day for us to #DoSomething to get @KamalaHarris elected! What a remarkable few months this has been — in record time, she’s built an extraordinary campaign, set forth a clear policy agenda, and proven again and again that she will be working not for herself, but for you. She’s done it all with intelligence, integrity, and grace. She has gone above and beyond. She’s more than done her part.
Tejaswi Kompala retweeted
#WeightLoss (14% vs 3% placebo + diet/exercise) with #Wegovy improved knee arthritis, STEP-9 published!
@nejm article
nejm.org/doi/full/10.1056/NE…
Tejaswi Kompala retweeted
After a strong start, competition for @novonordisk @EliLillyandCo is coming in the #weightloss space, with widespread innovation to bring options for more people @amgen @Roche @AltimmuneInc @StructureTx @Viking_VKTX @pfizer @Boehringer economist.com/business/2024/… @TheEconomist
Tejaswi Kompala retweeted
The benefits of incretin-memetic drugs (IMD) are clear 💉
The benefits of physical activity and nutrition therapy are clear 🏋️♂️🥦
This is not an either/or debate. A comprehensive weight management program should include both.
Figure Source: doi.org/10.1111/obr.13841
Tejaswi Kompala retweeted
*Breaking*
Top-line results positive of the highly anticipated #SOUL trial, the first powered CVOT of an oral #GLP1RA
14% reduction in MACE with oral semaglutide among 9,650 people with T2D and established CV disease and/or CKD
novonordisk.com/content/nnco…
Tejaswi Kompala retweeted
The paper “Physiology of the weight-loss plateau in response to diet restriction, GLP-1 receptor agonism, and bariatric surgery” was published today in @ObesitySociety is available here: onlinelibrary.wiley.com/doi/…
Tejaswi Kompala retweeted
It's time to review your #obesity treatment coverage! Will your health insurance cover obesity medication like the newly approved #Zepbound?
Here are some questions to ask: obesityaction.org/open-enrol…
@ObesityAction #OACAction
Tejaswi Kompala retweeted
Interested in personalized nutrition? Our new pub examining whether weight loss differs between genotype-concordant and genotype-discordant diets was published in @NatureComms and is featured as an Editors’ Highlight.
A thread on findings below.
Link: shorturl.at/JL238
Tejaswi Kompala retweeted
Retatrutide, the triple G, Glucagon-GIP-GLP-1 based triagonist produces substantial resolution of liver fat #NAFLD in PPL with #obesity #ADA2023 @ADA_DiabetesPro @AmDiabetesAssn #NASH trial coming
Tejaswi Kompala retweeted
This is preliminary data that needs to undergo peer review (presented as an abstract at ENDO) but incredibly relevant given AMA's new policy clarifying role of BMI as a measure in medicine. This data using DEXA suggests we are UNDERESTIMATING obesity, particularly among women and people who identify as Hispanic or Asian.
Using standard obesity cutoffs for both BMI and total body fat, this study found DEXA rated 74% of participants as having obesity based on body fat compared with 36% based on BMI.
Among the 64% of the study group who did not have obesity according to BMI, DEXA scans showed 53% of this subgroup did have obesity based on body fat percentages. Among those with a normal BMI, 43% had obesity according to DEXA.
Further analysis showed that adding waist circumference to BMI to enlarge the diagnostic net for obesity, it cut the percentage of adults missed as having obesity by BMI alone nearly in half.
Additional analyses showed that the rate of missed diagnoses of obesity by BMI was only most common among people of Hispanic or Asian ethnicity, with both groups showing a 49% rate of obesity by DEXA among those with normal-range BMIs.
Link to article: medscape.com/viewarticle/993…
Tejaswi Kompala retweeted
HUGE news in #diabetes and #cgm today. Looks like Medicare will finally agree to broader coverage of CGM, including for people using once-daily basal insulin.
drugdeliverybusiness.com/med…
Tejaswi Kompala retweeted
Eli Lilly announced today that it will cut the list prices for its most commonly prescribed insulins, including Humalog and Humulin, by 70%! The drug maker will also expand a program that caps insulin costs for patients at $35 per month. Full scoop - l8r.it/72SB
Tejaswi Kompala retweeted
As we rapidly accelerate toward this future of obesity, I would remind everyone that unless systemic changes are made which require changing fundamental structures of our society, this will be inevitable. Once people develop obesity, we have no evidence that the neurohormonal and immunologic changes are reversible, even with weight reduction. It’s why urgency regarding prevention is critical. I’m not going to lie; I don’t sense any urgency at the top level—no talk of obesity by major stakeholders.
Tejaswi Kompala retweeted
Our own @tkompala spoke with @healthITNews about our recent study on social determinants of health and how designing virtual care programs with health literacy in mind can ultimately lead to positive outcomes. Read the interview: healthcareitnews.com/news/de…
#VirtualCare
Tejaswi Kompala retweeted
Big News! House Appropriations Committee asks for Medicare Part D coverage of anti-obesity meds. If true, this would change the entire med coverage landscape as CMS often sets the bar for commercial payors. H/t @ConscienHealth pink.pharmaintelligence.info…
Tejaswi Kompala retweeted
Do you read package inserts? I ❤️them. Here are some useful tidbits from Mounjaro's PI (vs. semaglutide) that you should know before you rx your first one:
1/
#obesity #weight #weightloss #diabetes #endocrinology #pharmacology #pharmacy



























